Title : UBE2N Regulates Paclitaxel Sensitivity of Ovarian Cancer via Fos/P53 Axis.

Pub. Date : 2020

PMID : 33363381






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 UBE2N Regulates Paclitaxel Sensitivity of Ovarian Cancer via Fos/P53 Axis. Paclitaxel tumor protein p53 Homo sapiens
2 Furthermore, reversed regulation of Fos and P53 based on UBE2N reduction could reverse paclitaxel sensitivity, respectively. Paclitaxel tumor protein p53 Homo sapiens
3 Conclusion: Our study suggests that UBE2N could be used as a therapeutic agent for paclitaxel-resistant ovarian cancer through Fos/P53 pathway. Paclitaxel tumor protein p53 Homo sapiens